A startup out of Argonne National Lab and the Computation Institute (CEI) Navipoint Genomics LLC is developing a genomics analysis platform, which the CIE described as a "significant advancement in the rapidly evolving frontier of personalized medicine." The firm is building a HIPPA-compliant proof-of-concept that can be used in clinical practice. Providing advanced data transfer, sharing, and management, Navipoint is working on the development of an advanced genomics analysis platform, an nnovative technology that will allow the transfer and analyze full human genomes 50- to 100-times faster than competitive solutions, signiifcantly reducing the lengthtime of large-scale analysis.
